mechanism of glp 1 A Closer Look at the Dermatological Profile GLP-1 Agonists Mechanism of action for GLP-1R

Proposed Escalation Strategy A theoretical cagrilintide and retatrutide combination protocol might follow this gradual escalation approach: Weeks 1-4: Foundation Phase Cagrilintide: 0.6 mg weekly Retatrutide: 2 mg weekly Focus: Establishing tolerance to both compounds Monitoring: Gastrointestinal effects, appetite changes Weeks 5-8: Escalation Phase Cagrilintide: 1.2 mg weekly Retatrutide: 4 mg weekly Focus: Increasing receptor activation Monitoring: Weight changes, metabolic markers Weeks 9-12: Optimization Phase Cagrilintide: 2.4 mg weekly Retatrutide: 8 mg weekly Focus: Approaching therapeutic targets Monitoring: Comprehensive metabolic assessment Weeks 13+: Maintenance Phase Cagrilintide: 3.0-4.5 mg weekly Retatrutide: 8-12 mg weekly Focus: Sustained metabolic effects Monitoring: Long-term safety and efficacy This graduated approach mirrors the successful strategies used in cagrilintide 10mg research protocols, where slow escalation minimizes side effects while building therapeutic benefit

doi: 10.1016/j.jconrel.2024.01.051

The first week, I didnt notice much and almost stopped

Those using it as part of a longer anti-inflammatory program often start with a series of 4 to 6 sessions over several weeks

This makes it suitable for sensitive skin types that might react to other anti-aging ingredients

This semisolid preparation is dispensed in a pump mechanism, designed for convenient and controlled application on the skin